Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Cocaine addiction, craving and relapse

  • On-demand X-rays at synchrotron light sources

  • How racial stereotypes impact the way we communicate

  • Breakthrough measures Parkinson's progression in brain

  • Study identifies possible role for carbon monoxide in treating hemorrhagic stroke

  • Moderate drinking in later years may damage heart

  • Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies

  • Study examines association of genetic variants with cognitive impairment

  • Hospice use linked to fewer depressive symptoms for surviving spouses

  • Where there's a will ? well, there's another way

  •